Introduction to Radiomics.

PET artificial intelligence machine learning radiomics single-photon emission tomography

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
04 2020
Historique:
received: 22 08 2019
accepted: 28 01 2020
pubmed: 16 2 2020
medline: 29 9 2020
entrez: 16 2 2020
Statut: ppublish

Résumé

Radiomics is a rapidly evolving field of research concerned with the extraction of quantitative metrics-the so-called radiomic features-within medical images. Radiomic features capture tissue and lesion characteristics such as heterogeneity and shape and may, alone or in combination with demographic, histologic, genomic, or proteomic data, be used for clinical problem solving. The goal of this continuing education article is to provide an introduction to the field, covering the basic radiomics workflow: feature calculation and selection, dimensionality reduction, and data processing. Potential clinical applications in nuclear medicine that include PET radiomics-based prediction of treatment response and survival will be discussed. Current limitations of radiomics, such as sensitivity to acquisition parameter variations, and common pitfalls will also be covered.

Identifiants

pubmed: 32060219
pii: jnumed.118.222893
doi: 10.2967/jnumed.118.222893
pmc: PMC9374044
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

488-495

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Med Image Anal. 2019 May;54:253-262
pubmed: 30954852
Nature. 2013 Sep 19;501(7467):338-45
pubmed: 24048066
Carcinogenesis. 2017 Sep 1;38(9):900-909
pubmed: 28911002
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):864-877
pubmed: 30535746
IEEE Trans Med Imaging. 2019 Mar;38(3):675-685
pubmed: 30222554
Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):446-454
pubmed: 30145701
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
Acta Oncol. 2010 Oct;49(7):1012-6
pubmed: 20831489
Sci Rep. 2015 Aug 05;5:11075
pubmed: 26242464
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):133-141
pubmed: 26219871
Clin Cancer Res. 2019 Jul 15;25(14):4271-4279
pubmed: 30975664
IEEE Trans Biomed Eng. 2014 Mar;61(3):630-7
pubmed: 24108747
J Nucl Med. 2012 May;53(5):693-700
pubmed: 22454484
Sci Rep. 2015 Aug 17;5:13087
pubmed: 26278466
J Nucl Med. 2015 Nov;56(11):1667-73
pubmed: 26229145
Oncotarget. 2016 Mar 1;7(9):10051-63
pubmed: 26840267
Sci Rep. 2019 Jul 4;9(1):9649
pubmed: 31273242
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Sci Rep. 2018 Sep 6;8(1):13328
pubmed: 30190592
Mol Imaging Biol. 2016 Oct;18(5):788-95
pubmed: 26920355
Phys Med Biol. 2016 Jul 7;61(13):R150-66
pubmed: 27269645
Theranostics. 2018 Nov 12;8(21):5915-5928
pubmed: 30613271
Mol Imaging Biol. 2019 Oct;21(5):954-964
pubmed: 30671740
Br J Cancer. 2015 Jun 9;112(12):1882-7
pubmed: 25989271
Oncotarget. 2016 Oct 11;7(41):67302-67313
pubmed: 27589833
Neuroimage. 2011 May 15;56(2):497-507
pubmed: 20709176
J Neurosci Methods. 1996 Nov;69(2):123-36
pubmed: 8946315
J Nucl Med. 2019 Jun;60(6):864-872
pubmed: 30389820
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2715-2721
pubmed: 31190176
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2638-2655
pubmed: 31240330
Neuroimage. 2018 Jul 1;174:550-562
pubmed: 29571715
Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):455-466
pubmed: 30173391
Exp Mol Med. 2018 Jan 5;50(1):e416
pubmed: 29303512
Cancer Res. 2012 Aug 1;72(15):3725-34
pubmed: 22710433
Sci Rep. 2017 Oct 16;7(1):13206
pubmed: 29038455
Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2324-2335
pubmed: 27325312
Radiologe. 2018 Nov;58(Suppl 1):1-6
pubmed: 29922965
Med Image Anal. 2016 Aug;32:257-68
pubmed: 27236221
Clin Radiol. 2017 Jan;72(1):3-10
pubmed: 27742105
Clin Pharmacol Ther. 2012 Oct;92(4):422-4
pubmed: 22910443
J Nucl Med. 2019 Apr;60(4):451-458
pubmed: 30733322
Rofo. 2016 Jul;188(7):652-61
pubmed: 27139177
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2760-2769
pubmed: 31286200
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929
J Nucl Med. 2018 Aug;59(8):1321-1328
pubmed: 29301932
Med Phys. 2019 Feb;46(2):665-678
pubmed: 30506687
J Nucl Med. 2017 Apr;58(4):569-576
pubmed: 27688480

Auteurs

Marius E Mayerhoefer (ME)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York mayerhom@mskcc.org.
Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Andrzej Materka (A)

Institute of Electronics, Lodz University of Technology, Lodz, Poland.

Georg Langs (G)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

Ida Häggström (I)

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Piotr Szczypiński (P)

Institute of Electronics, Lodz University of Technology, Lodz, Poland.

Peter Gibbs (P)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.

Gary Cook (G)

Cancer Imaging Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom; and.
King's College London and Guy's and St. Thomas' PET Centre, St. Thomas' Hospital, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH